Abiopharma

Kodiak Sciences to Present at Upcoming Investor Conferences

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

New SEC Form for ResMed Inc.

UTHR: Notification

UTHR: Notification

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026

Cross Country Healthcare Announces Third Quarter 2025 Financial Results